Visual morbidity in thirty-four families with Schnyder crystalline corneal dystrophy (an American Ophthalmological Society thesis)
- PMID: 18427632
- PMCID: PMC2258126
Visual morbidity in thirty-four families with Schnyder crystalline corneal dystrophy (an American Ophthalmological Society thesis)
Abstract
Purpose: To assess the findings, visual morbidity, and surgical intervention in Schnyder crystalline corneal dystrophy (SCCD).
Methods: Retrospective case series of 115 affected individuals from 34 SCCD families identified since 1989. Age, uncorrected visual acuity, best-corrected visual acuity (BCVA), corneal findings, and ocular surgery were recorded. Prospective phone, e-mail, or written contact provided updated information. Patients were divided into 3 age categories for statistical analysis: less than 26 years of age, 26 to 39 years of age, and 40 years of age and older.
Results: Mean age on initial examination was 38.8 +/- 20.4 (range, 2-81) with follow-up of 55 of 79 (70%) of American patients. While there were no statistical significant correlations between logMAR visual acuity and age (logMAR BCVA =.033 + .002 x age; R =.21), the linear regression showed the trend of worse visual acuity with age. BCVA at > or =40 years was decreased compared to <40 (P < .0001), although mean BCVA was > 20/30 in both groups. Twenty-nine of 115 patients had corneal surgery with 5 phototherapeutic keratectomy (3 patients), and 39 penetrating keratoplasty (PKP) (27 patients). PKP was reported in 20 of 37 (54%) patients > or =50 years and 10 of 13 (77%) of patients > or =70. BCVA 1 year prior to PKP in 15 eyes (9 patients) ranged from 20/25 to 20/400 including 7 eyes with other ocular pathology. BCVA in the remaining 8 eyes was 20/25 to 20/70 with 3 of these 4 patients reporting preoperative glare. Chart and phone survey suggested increasing difficulty with photopic vision with aging.
Conclusion: Although excellent scotopic vision continues until middle age in SCCD, most patients had PKP by the 7th decade. SCCD causes progressive corneal opacification, which may result in glare and disproportionate loss of photopic vision.
Figures
References
-
- Shearman AM, Hudson TJ, Andresen JM, et al. The gene for Schnyder's crystalline corneal dystrophy maps to human chromosome 1p34.1–p36. Hum Mol Genet. 1996;5:1667–1672. - PubMed
-
- Aldave AJ, Rayner SA, Principe AH, et al. Analysis of fifteen positional candidate genes for Schnyder's crystalline corneal dystrophy. Mol Vis. 2005;11:713–716. - PubMed
-
- Theendakara V, Tromp G, Kuivaniemi H, et al. Fine mapping of the Schnyder's crystalline corneal dystrophy locus. Hum Genet. 2004;144:594–600. - PubMed
-
- Riebeling P, Polz S, Tost F, et al. [Schnyder's crystalline corneal dystrophy. Further narrowing of the linkage interval at chromosome 1p34.1–p36?] Ophthalmologe. 2003;100:979–983. - PubMed
-
- Weiss JS, Kruth HS, Kuvaniemi H, et al. Mutations in UBIAD1 gene on chromosome short arm 1, region 36, cause Schnyder crystalline corneal dystrophy. Invest Ophthalmol Vis Sci. 2007;48:5007–5012. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources